FBRX
Forte Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$442.14M
P/E Ratio
—
EPS
$-4.58
Beta
3.00
52W High
$35.80
52W Low
$7.78
50-Day MA
$26.86
200-Day MA
$21.70
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Forte Biosciences Inc
Forte Biosciences Inc. is a clinical-stage biopharmaceutical company in the United States. The company is headquartered in Torrance, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-76.90M |
| Operating Margin | 0.00% |
| Return on Equity | -188.40% |
| Return on Assets | -83.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.03 |
| Price-to-Book | 10.56 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.87 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $20.48M |
| Float | $18.83M |
| % Insiders | 2.15% |
| % Institutions | 70.55% |
Historical Volatility
HV 10-Day
92.23%
HV 20-Day
80.71%
HV 30-Day
87.76%
HV 60-Day
91.62%
HV Rank
26.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($63.75 target)
5
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026